Related Experiment Video
Updated: Dec 27, 2025
07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
9.2K
Multidisciplinary Real-World Experience With Bilastine, a Second Generation Antihistamine
Journal of Drugs in Dermatology : JDD
|March 5, 2020
Summary
Second-generation antihistamine bilastine effectively treats allergic conditions like rhinitis and urticaria. This study shows bilastine provides favorable outcomes, proving safe and well-tolerated for diverse patient populations.
Area of Science:
- Dermatology
- Allergology
- Pharmacology
Background:
- Allergic conditions necessitate antihistamine treatment.
- First-generation antihistamines can cause adverse effects, including impaired cognitive function and sleep disturbances.
- Second-generation antihistamines, like bilastine, offer effective allergy symptom relief without these side effects.
Purpose of the Study:
- To evaluate the real-world application of bilastine in managing various allergic conditions.
- To optimize patient care by highlighting bilastine's role in antihistamine therapy.
- To present evidence-based patient cases supported by existing literature.
Main Methods:
- A real-world case project was implemented.
- Patient cases involving bilastine were collected and analyzed.
- Literature evidence was used to support case discussions.
Main Results:
- Bilastine was used for perennial/seasonal allergic rhinitis, chronic urticaria, urticarial vasculitis, and inflammatory skin pruritus.
- Patients ranged from 9 to 76 years old, covering a wide demographic.
- Favorable outcomes were observed in treated patients.
Conclusions:
- Real-world cases demonstrate bilastine's effectiveness in treating allergic conditions.
- Bilastine was found to be safe and well-tolerated across a spectrum of patients.
- The study supports bilastine as a beneficial second-generation antihistamine option.
More Related Videos
Related Concept Videos
01:15Upper Respiratory Drugs: First and Second-Generation Antihistamines
895
Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
895
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.6K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.6K
02:07Blind Procedures
12.7K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
12.7K
01:19Antiasthma Drugs: Leukotriene Modifiers
1.6K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.6K
01:27Allergic Drug Reactions
1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
1.6K
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
1.6K